Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses Vs Continuous Infusion in Diabetic Patients with Septic Shock: A Prospective Cohort Study
Global Journal of Critical Care and Emergency Medicine · 2024
DOI: 10.33425/3065-5641.1008 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Global Journal of Critical Care and Emergency Medicine, 2024. Verfasst von Swathy K und 7 weiteren Autor:innen.
Themen: Sepsis
Abstract (Originalsprache)
Background & Objectives: Septic shock is a serious condition associated with a high mortality rate because of the multiorgan dysfunction caused by dysregulated host immune responses to infection. Giving low dose steroids in septic shock patients has been shown to hasten the reversal of shock and current Surviving Sepsis Guidelines (SSG) also suggest using low dose steroids for the same. Also, the use of steroids causes hyperglycaemia particularly in diabetic patients. The current SSG does not specify the method of administration. The primary objective of our study was to compare continuous infusion vs intermittent boluses of hydrocortisone to obtain a better glycaemic control.
Methods
A prospective cohort study was conducted in diabetic patients with septic shock admitted in Multi Disciplinary Intensive Care Unit (MDICU) of PRS hospital from July 2022 to February2023. Hydrocortisone was given as continuous infusion in 55 subjects and the remaining 55 received intermittent boluses of hydrocortisone and average blood glucose values were measured in both the groups.
Results
Among 110 patients, 55 patients each received continuous infusion and intermittent boluses of hydrocortisone respectively. The mean blood glucose values in continuous infusion group were 161.1 ± 22.7 and 172.5 ± 21.0 (mg/ dl) in intermittent boluses group which was statistically significant with a p value of 0.007. There was no statistically significant difference among the groups in 28-day mortality, ICU length of stay (LOS), hospital LOS, or other secondary safety outcomes.
Conclusions
This study infers that giving hydrocortisone as continuous infusions in septic shock patients leads to better glycaemic control when compared to intermittent boluses of hydrocortisone, without any difference in 28-day mortality.
Zitieren
APA
K, S., J, N., P, V., VU, A., Mithun, R., Sreelekshmi, S., PR, S., & Oommen, O. V. (2024). Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses Vs Continuous Infusion in Diabetic Patients with Septic Shock: A Prospective Cohort Study. Global Journal of Critical Care and Emergency Medicine. https://doi.org/10.33425/3065-5641.1008
Vancouver
K S, J N, P V, VU A, Mithun R, Sreelekshmi S, et al. Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses Vs Continuous Infusion in Diabetic Patients with Septic Shock: A Prospective Cohort Study. Global Journal of Critical Care and Emergency Medicine. 2024. doi:10.33425/3065-5641.1008
BibTeX
@article{K2024,
author = {K, Swathy and J, Naveen and P, Vivek and VU, Akhilesh and Mithun, Rathenmurugan and Sreelekshmi, Sreenath and PR, Sudhakaran and Oommen, Oommen V},
title = {Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses Vs Continuous Infusion in Diabetic Patients with Septic Shock: A Prospective Cohort Study},
journal = {Global Journal of Critical Care and Emergency Medicine},
year = {2024},
doi = {10.33425/3065-5641.1008}
}
EUVIMED